Pyxis Oncology, Inc. (PYXS)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
Oct 09, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Price : 2.03 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 1.99 | 2.06 | 1.98 | 2.03 | 950416.0 |
| Oct 08, 2026 | 2.03 | 2.03 | 1.902 | 1.99 | 1.097M |
| Oct 07, 2026 | 2.02 | 2.086 | 2.00 | 2.01 | 957973.0 |
| Oct 06, 2026 | 2.22 | 2.22 | 2.00 | 2.02 | 1.405M |
| Oct 05, 2026 | 2.12 | 2.260 | 2.05 | 2.24 | 1.517M |
| Oct 02, 2026 | 2.21 | 2.31 | 2.10 | 2.14 | 2.000M |
| Oct 01, 2026 | 2.31 | 2.31 | 2.19 | 2.19 | 2.605M |
| Sep 30, 2026 | 2.375 | 2.41 | 2.12 | 2.33 | 8.150M |
| Sep 29, 2026 | 2.94 | 2.94 | 2.83 | 2.90 | 335463.0 |
| Sep 28, 2026 | 2.81 | 2.91 | 2.75 | 2.90 | 368422.0 |
| Sep 25, 2026 | 2.91 | 2.92 | 2.785 | 2.86 | 609802.0 |
| Sep 24, 2026 | 3.22 | 3.25 | 2.86 | 2.92 | 879402.0 |
| Sep 23, 2026 | 3.36 | 3.36 | 3.20 | 3.22 | 433865.0 |
| Sep 22, 2026 | 3.21 | 3.405 | 3.19 | 3.355 | 480074.0 |
| Sep 21, 2026 | 3.38 | 3.38 | 3.19 | 3.19 | 633191.0 |
| Sep 18, 2026 | 3.38 | 3.440 | 3.33 | 3.33 | 564354.0 |
| Sep 17, 2026 | 3.43 | 3.472 | 3.339 | 3.41 | 476769.0 |
| Sep 16, 2026 | 3.34 | 3.42 | 3.32 | 3.34 | 640082.0 |
| Sep 15, 2026 | 3.40 | 3.42 | 3.24 | 3.33 | 489669.0 |
| Sep 14, 2026 | 3.21 | 3.515 | 3.21 | 3.43 | 699691.0 |
| Sep 11, 2026 | 3.31 | 3.42 | 3.07 | 3.21 | 1.129M |
| Sep 10, 2026 | 3.42 | 3.437 | 3.18 | 3.27 | 742142.0 |
| Sep 09, 2026 | 3.48 | 4.12 | 3.132 | 3.38 | 4.345M |
| Sep 08, 2026 | 4.00 | 4.15 | 3.845 | 3.89 | 1.376M |
| Sep 04, 2026 | 3.53 | 4.05 | 3.515 | 3.89 | 2.231M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.92 |
| Vericel Corp. | 40.10 |
Price Related Metrics
| PS Ratio | 11.62 |
| Price to Book Value | 11.26 |
| Earnings Yield | -69.13% |
| Market Cap | 128.77M |